EUS-FNA for pancreato-biliary cancers as preoperative study method to evaluate paraaortic lymph node metastasis.

EUS-FNA for pancreato-biliary cancers as preoperative study method to evaluate paraaortic lymph node metastasis. - EUS-FNA study for preoperative pancreato-biliary cancers

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006408

Enrollment

Registered

2011-10-30

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer, biliary tract cancer

Interventions

The number of patients until Des 2016.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Preoperative state of pancreatic cancer or bliary tract cancer, (2) PS1 or 2

Exclusion criteria

Exclusion criteria: (1) Patients who have allergy for contrast medium (2) Patients with bleeding tendency (3) Patients under anticoaglant therapy (4) Plt< 30000

Design outcomes

Primary

Measure	Time frame
Evaluate the efficacy of EUS-FNA for paraaortic lymph nodes.	—

Secondary

Measure	Time frame
(1) comparison with FDG-PET, (2)complications, (3) quality of specimen material	—

Countries

Japan

Contacts

Public ContactAkira Kurita

Kyoto University Department of gastroenterology ahd hepatology

akurita@kuhp.kyoto-u.ac.jp075-751-4319

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026